"

yabo.com

"

Anhui Biocompounds Chemicals Co., Ltd.

With a registered capital of 50 million yuan and an area of 118 acers, it is an innovative enterprise integrating the R & D, production and operation of pesticide technical drugs, pesticide preparations and pharmaceutical intermediates. Anhui Biocompounds Chemicals is based on chemistry and focuses on pesticides and medicine. It is good at hydrogenation, nitration, amination, chlorination, cracking, addition, cyclization and other reactions. It has a daily wastewater treatment capacity of 600 tons / day, as well as a 20000 m3 / h RTO gas incineration device, equipped with SIS / DCS and other safety and automation systems. It has complete production facilities, perfect safety and environmental qualification, and has supporting qualification for the storage and use of hazardous chemicals. The enterprise has passed ISO9001 quality management system certification, ISO14001 environmental management system certification and OHSAS18001 occupational health and safety management system certification.

Production Capacity:

The first phase of the project was completed and put into use in 2010, forming a kiloton production workshop of acetamiprid, a production workshop of 2-chloro-5-chloromethylpyridine and a 150 tons per year production workshop of bifenthrin and other pesticide technical drugs and intermediates.

The second phase of the project is constructed according to the requirements of the latest Petrochemical regulations. After the completion of the project, the production workshop with an annual output of 500 tons per year and the production capacity of 928 tons per year of pharmaceutical intermediates are increased.

After the above transformation, it has six complete fine chemical and pharmaceutical intermediate production workshops. The whole plant is equipped with nearly 200 500L-8000L reactors, with a total volume of more than 500000 cubic meters,All kinds of storage tanks, pipe racks and bridges, solid-liquid separation equipment, distillation and distillation equipment and drying and packaging devices are complete. The types of reactions that can be carried out include hydrogenation, nitration, amination, chlorination, cracking, addition, cyclization, high temperature, ultra-low temperature, acyl chlorination, etc. The production line is multi-functional and can be continuously invested according to the requirements of sealing, pipelining, automation and informationization.

    

Auxiliary Equipment and Facilities:

Utilities: 6000KVA dual power distribution system, ethylene glycol refrigeration system and TCU high and low temperature automatic control system, high temperature oil furnace system, tank farm transportation system, liquid nitrogen / nitrogen generator protection system.

Wastewater treatment: the sewage treatment station in the plant has a total investment of nearly 30 million yuan, a three-hour treatment system with a sewage treatment capacity of 500 T/D and a daily treatment capacity of 60 T/D, perfect rainwater and sewage diversion, and is equipped with multi-point detection equipment and online monitoring facilities.

Waste gas treatment: RTO device with air volume of 20000m3 / h and activated carbon adsorption and desorption device for halogen containing tail gas with air volume of 5000m3 / h are detected at the end line of exhaust pipe and discharged up to standard. Hazardous waste warehouse: 350m2 hazardous waste warehouse, with explosive, toxic and highly toxic products warehouse, class a warehouse, class B warehouse, class C warehouse and class D warehouse, which are equipped with various monitoring devices for standardized management.




 

Anhui Biocompounds Pharmaceutical Co., Ltd.

With a registered capital of 120 million yuan and an area of 290 acers, it is a high-tech innovative enterprise integrating R & D, production and sales.

The enterprise has passed ISO9001 quality management system certification, ISO14001 environmental management system certification and OHSAS18001 occupational health and safety management system certification, established Chizhou enterprise technology R & D center, and passed GMP on-site verification at the end of 2021. In order to accelerate the progress of scientific and technological innovation and technological transformation and better attract scientific and technological talents, the "small molecule targeted drug research institute" was officially established in the company in September 2018, and two R & D buildings are under construction.

Production Capacity:

The first phase of the project has carried out partial technical transformation on the equipment and facilities of the existing first and second workshops and auxiliary rooms to form a production workshop of pharmaceutical varieties such as levofloxacin intermediates with an annual output of 1200 tons / year.

The second phase of the project plans to build a production line with an annual output of 100 tons of small molecule targeted antitumor drugs and intermediates, and a production line with an annual output of 1000 tons of cardiovascular, antidepressant, antiviral and other drugs. Phase II project will be equipped with comprehensive building, R & D building, quality inspection building, various warehouses, storage tank area (including pump area), etc.

After the above transformation, there will be three intermediate production workshops, three GMP workshops and independent hydrogenation workshops. Nearly 300 sets of 500L-10000L reactors with a total volume of more than 600000 cubic meters are equipped to meet various reactions such as acylation, amination, cyclization, condensation, hydrolysis, hydrogenation, reduction and cyanidation.

    

 

 

Auxiliary Equipment and Facilities:

Utilities: water, electricity, steam, refrigeration, air pressure and nitrogen protection systems are complete.

Waste gas treatment: after treatment, the waste gas from the production workshop passes through 20000 m3 / h air volume RTO, and online detection is realized at the end of the exhaust pipe to meet the discharge standard.

Waste water treatment: the total investment of the sewage treatment system in the plant area is nearly 60 million yuan, the treatment scale is 1500T / D, the corresponding sewage detection equipment and online detection facilities are equipped, and the professional membrane treatment desalination device is equipped.




"yabo.com <rt id="geqo8"><small id="geqo8"></small></rt>
<acronym id="geqo8"></acronym>
<rt id="geqo8"></rt>
<acronym id="geqo8"></acronym>
"